Ikarian Capital’s IO Biotech IOBT Stock Holding History

Ikarian Capital’s Portfolio IOBT Stock Details IOBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,386,565	Closed	-$81.4K	–	168
2026 Q1	$81.4K	Hold	1,386,565	–	–	0.01%	150
2025 Q4	$844K	Sell	1,386,565 -139,328	-9%	-$104K	0.07%	130
2025 Q3	$554K	Buy	+1,525,893	New	+$2.63M	0.06%	135

Ikarian Capital's IOBT Position: Q2 2026 in Review

Ikarian Capital sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 1,386,565 shares — an estimated $81.4K sold.

Ikarian Capital first reported a position in IOBT in Q3 2025 and held it in 3 quarters. The position peaked at $844K in Q4 2025. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

Ikarian Capital reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
Ikarian Capital sold 1,386,565 IO Biotech shares in Q2 2026, an estimated $81.4K.
Ikarian Capital first reported a position in IO Biotech in Q3 2025 and held it in 3 quarters.
Ikarian Capital's IO Biotech position peaked at $844K in Q4 2025.
0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.